Understanding FIGO Staging for Gestational Trophoblastic Neoplasia and Its Treatment Implications
Gestational trophoblastic neoplasia (GTN) represents a group of rare tumors that arise from abnormal growth of trophoblastic tissue, which normally forms part of the placenta during pregnancy. Accurate diagnosis and effective management of GTN depend heavily on proper staging. The International Federation of Gynecology and Obstetrics (FIGO) staging system plays a crucial role in this process. It helps clinicians classify the disease, predict prognosis, and guide treatment decisions.
